Investing.com - Sanara Medtech reported on Monday third quarter earnings that matched analysts' forecasts and revenue that fell short of expectations.
Sanara Medtech announced earnings per share of $-0.32 on revenue of $13M. Analysts polled by Investing.com anticipated EPS of $-0.32 on revenue of $14.7M.
Sanara Medtech shares are up 14% from the beginning of the year, still down 2.72% from its 52 week high of $35.69 set on November 14.
Sanara Medtech follows other major Healthcare sector earnings this month
Sanara Medtech's report follows an earnings beat by J&J on October 18, who reported EPS of $2.55 on revenue of $23.79B, compared to forecasts EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on November 1 with third quarter EPS of $1.98 on revenue of $6.94B, compared to forecast for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar